Carcinoid Tumor Market information presented through more than 50 market data tables and figures spread over 90 pages of the report. Avail the in-depth table of content (TOC) & market synopsis on MarketResearchFuture.com – Forecast till 2023.
Carcinoid tumor is a type of the neuroendocrine tumor. The most common site of carcinoid tumors is the GI (gastrointestinal) tract and the lungs. However, it can also be developed in pancreas, testicles, and ovaries. The increasing prevalence of the carcinoid tumor is expected to drive the market growth. According to the American Society of Clinical Oncology (ASCO) in 2016, approximately 8,000 adults in the US were diagnosed with a carcinoid tumor in their GI tract. Moreover, it was also estimated that each year approximately 4,000 adults in the US are diagnosed with a carcinoid tumor in their lung. Moreover, growing geriatric population along with rising healthcare expenditure is likely to boost the market growth during the forecast period. However, lack of awareness, high treatment cost and related side effects may hamper the market growth during the forecast period. The Global Carcinoid Tumor Market Is Expected To Grow At An Approximate Of CAGR Of 10.5% During Forecast Period.
Ask for Sample copy @ https://www.marketresearchfuture.com/sample_request/4813 .
The global carcinoid tumor market is segmented on the basis of site, diagnosis, treatment, and end users. On the basis of the site, the market is segmented into gastrointestinal, lung, and others. Furthermore, the gastrointestinal segment is sub-segmented into rectum, small intestine, appendix, and others. Lung segment is sub-segmented into typical, atypical, and others. On the basis of the diagnosis, the market is segmented into serology, imaging, biopsy, and others. The serology segment is sub-segmented into blood test, urine test, molecular test, and others. The imaging segment is sub-segmented into X-ray, CT scan, PET scan, and others. On the basis of the treatment, the market is segmented into surgery, chemotherapy, radiotherapy, and others. The surgery segment is sub-segmented into local excision, radiofrequency ablation (RFA), and others. On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, research organization, and others.
Carcinoid Tumor Market Regional Analysis:
America dominates the global carcinoid tumor market owing to a well-developed healthcare sector and huge patient population. Apart from this, increasing healthcare expenditure and presence of developed economies like the U.S. and Canada within the region have boosted the growth of the market in America.
Europe is the second leading market across the globe, which is followed by Asia Pacific owing to availability of funds for research, huge patient population, and strong government support for research & development. According to the National Health Service in 2015, each year about 1,200 people are diagnosed with carcinoid tumor in the UK.
Asia Pacific is the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies like India and China, which have rising healthcare expenditure. Moreover, favorable governmental policies and the presence of huge opportunity in the untapped market within the region are likely to fuels the market growth during the forecast period.
On the other hand, the Middle East & Africa holds the least share in the Global Carcinoid Tumor Market due to presence of poor economy, especially, in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. The presence of developed economies like Qatar, Saudi Arabia, Dubai, and others within the region fuels the market growth.
Carcinoid Tumor Market Key Players are:
Novartis AG (Europe), Amgen Inc. (U.S.), Boehringer Ingelheim GmbH (Europe), AVEO Pharmaceuticals, Inc. (U.S.), Chiasma, Inc. (U.S.), Aegis Therapeutics, LLC (U.S.), CRINETICS PHARMACEUTICALS (U.S.), Delcath Systems Inc. (U.S.), Exelixis, Inc. (U.S.), and others.
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
LIST OF TABLES
Table 1 Cancer Industry Synopsis, 2017 – 2023
Table 2 Global Carcinoid Tumor Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Carcinoid Tumor Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Carcinoid Tumor Market By Site, 2017 – 2023, (USD Million)
Table 5 Global Carcinoid Tumor Market By Diagnosis, 2017 – 2023, (USD Million)
Check Discount @ https://www.marketresearchfuture.com/check-discount/4813 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312